BEIZRAY

NDC 70710-2092 · Zydus Pharmaceuticals USA Inc.

Generic nameDocetaxel

Dosage formINJECTION, SOLUTION

RouteINTRAVENOUS

Active ingredient(s)DOCETAXEL ANHYDROUS

Strength20 mg/mL

Pharmacologic classMicrotubule Inhibition [PE], Microtubule Inhibitor [EPC]

Marketing categoryNDA

Packages

70710-2092-8 — 1 VIAL, GLASS in 1 CARTON (70710-2092-8) / 1 mL in 1 VIAL, GLASS

J9174 — Injection, docetaxel (beizray), 1 mg Medicare Part B payment limit (ASP + 6%): $46.81

FDA lists these products with the same active ingredient.

55150-378 — Docetaxel, 55150-379 — Docetaxel, 55150-380 — Docetaxel, 62332-678 — Docetaxel, 67457-531 — DOCETAXEL ANHYDROUS, 67457-532 — DOCETAXEL ANHYDROUS, 67457-533 — DOCETAXEL ANHYDROUS, 68083-399 — Docetaxel, 68083-400 — Docetaxel, 68083-401 — Docetaxel, 70121-1221 — Docetaxel, 70121-1222 — Docetaxel, 70121-1223 — Docetaxel, 70710-2152 — Docetaxel, 71288-144 — Docetaxel anhydrous, 72078-040 — DOCETAXEL ANHYDROUS, 72078-086 — DOCETAXEL ANHYDROUS, 72078-087 — DOCETAXEL ANHYDROUS, 83513-008 — Docetaxel, 83513-009 — Docetaxel, +15 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.